Surgery for Stage IIIa N2 Disease

Filmed at the 2016 EACTS Annual Meeting in Barcelona, Spain, Leanne Harling of Imperial College in London, UK, moderates a discussion on the role of surgical therapy for N2 lung cancer. Doug Mathisen of Massachusettes General Hospital in Boston, Massachusetts, and Erino Rendina of the University La Sapienza in Rome, Italy, share and debate their approaches to staging, adjuvant therapy, persistent disease, and surgical removal of the primary tumor.




CC BY 4.0